具有融合能力的疫苗:广泛中和艾滋病毒初级分离物
R A LaCasse1, K E Follis, M Trahey
1The Montana Biotechnology Center and Division of Biological Sciences, University of Montana, Missoula, MT 59812, USA.
概括
新的艾滋病毒疫苗免疫原体捕获病毒融合结构,产生针对24个患者分离物中的23个广泛中和抗体. 这种方法可能会导致更有效的人类免疫缺陷病毒 (HIV) 疫苗.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 疫苗开发 疫苗开发
背景情况:
- 目前的人类免疫缺陷病毒 (HIV) gp120蛋白质候选疫苗未能诱导能中和多种原发性HIV分离物的抗体.
- 中和抗体对于有效的艾滋病毒疫苗至关重要,但实现广泛的中和仍然是一个重大挑战.
研究的目的:
- 开发新的艾滋病毒疫苗免疫原体,引起广泛中和抗体.
- 调查"融合能力"免疫原体的潜力,这些免疫原体在病毒进入过程中模仿过渡的信封-CD4核受体结构.
主要方法:
- 生产甲固定的全细胞HIV疫苗免疫原体,旨在捕获具有融合能力的结构.
- 用新型免疫原体对转基因小鼠模型进行免疫.
- 评估产生的抗体对来自不同类型 (A-E) 的原发性艾滋病毒分离物的小组中和的能力.
主要成果:
- 这种依赖于融合的免疫基因在转基因小鼠模型中成功产生了抗体.
- 这些抗体对24种不同原发性艾滋病毒分离物中的23种表现出强烈的中和活性.
- 中和范围涵盖了多个艾滋病毒遗传类 (A-E) 和地理来源.
结论:
- 开发具有融合能力的HIV免疫原体是广泛有效的HIV疫苗的有希望的战略.
- 在融合过程中捕获短暂的病毒结构可能是产生交叉中和抗体的关键.
- 这种方法有可能推动艾滋病毒疫苗开发向临床应用发展.
相关概念视频
Vaccinations
Overview
Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


